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Abstract
RANTES (CCL5) is a chemokine expressed by many hematopoietic and non-hematopoietic cell types that plays an important
role in homing and migration of effector and memory T cells during acute infections. The RANTES receptor, CCR5, is a major
target of anti-HIV drugs based on blocking viral entry. However, defects in RANTES or RANTES receptors including CCR5 can
compromise immunity to acute infections in animal models and lead to more severe disease in humans infected with west
Nile virus (WNV). In contrast, the role of the RANTES pathway in regulating T cell responses and immunity during chronic
infection remains unclear. In this study, we demonstrate a crucial role for RANTES in the control of systemic chronic LCMV
infection. In RANTES
2/2 mice, virus-specific CD8 T cells had poor cytokine production. These RANTES
2/2 CD8 T cells also
expressed higher amounts of inhibitory receptors consistent with more severe exhaustion. Moreover, the cytotoxic ability of
CD8 T cells from RANTES
2/2 mice was reduced. Consequently, viral load was higher in the absence of RANTES. The
dysfunction of T cells in the absence of RANTES was as severe as CD8 T cell responses generated in the absence of CD4 T cell
help. Our results demonstrate an important role for RANTES in sustaining CD8 T cell responses during a systemic chronic
viral infection.
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Introduction
During many chronic infections, virus spreads rapidly from the
site of initial infection to distal tissues. T cells, on the other hand,
must first become activated in the LNs and spleen and then gain
the ability to migrate to infected organs. Chemokines play a key
role in orchestrating all stages of this T cell response from
recruitment of naı ¨ve T cells to inflamed lymphoid tissue, migration
of T cells within lymphoid organs, movement of activated T cells
from lymphoid tissues to effector sites, and the movement of
effector T cells within non-lymphoid tissues [1]. While chemokine
receptor-ligand pairs such as CCR7-CCL19/21 and CXCR5-
CXCL13 are important for migration of T cells into and within
lymphoid tissues, others such as CCR4-CCL17/22 and CCR10-
CCL27/28 are important for T cell migration into peripheral
tissues [2].
One chemokine that has been shown to play a role in immune
responses to viral infections is the beta chemokine RANTES
(regulated on activation normal T cell expressed and secreted).
While RANTES was originally considered a T cell-specific
chemokine, it is now known to be expressed by a number of
other cell types including epithelial cells and platelets and acts as a
potent chemoattractant for many cell types such as monocytes,
NK cells [3], memory T cells [4], eosinophils [5] and DCs [6]. A
receptor for RANTES, CCR5, is a G protein coupled receptor
that, in addition to being the major receptor for RANTES, can
also bind MIP1a (CCL3) and MIP1b (CCL4). While the
importance of these and many other chemokine:chemokine
receptor pathways has been examined following acute infection
or immunization, the role of specific chemokines in regulating T
cell responses to chronic viral infections is less clearly defined.
One role for chemokines in regulating T cell responses is the
regulation of spatial organization and cellular interactions within
lymphoid tissues. For the initiation of an immune response, rare
antigen-specific lymphocytes must come into contact with peptide-
presenting APCs. Castellino et al showed that antigen-specific
interactions of CD4 T cells with antigen-bearing DCs leads to the
local production of MIP1a and MIP1b that then recruits naı ¨ve
CD8 T cells to the same peptide-presenting DC activated by the
CD4 T cell [7]. Thus, these chemokines can contribute to the
provision of CD4 T cell help for optimal CD8 T cell priming.
While Castellino et al found only a modest effect of RANTES
neutralization in their protein immunization system, the relative
importance of MIP-1a, MIP-1b and RANTES during infection is
unknown. Given the overlap in the function of MIP-1a, MIP-1b
and RANTES, these studies suggest a potential role for RANTES
early in T cell responses to infection possibly via CD4 help. The
importance of CD4 T cell help has long been appreciated for a
number of chronic viral infections including LCMV, HCV and
HIV [8,9,10]. When CD4 T cells are transiently depleted at the
time of infection with LCMV clone 13, the mice become viremic
for life in contrast to untreated mice that control viremia in 2–3
months [8]. Moreover, the CD8 T cells in the CD4 depleted mice
are more severely exhausted [11]. Thus, chemokines play
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organization of tissues and in regulating cell-cell interactions.
RANTES regulates protective immunity to viral infections. For
example, lymphocytes and epithelial cells produce RANTES in
response to infection with respiratory syncytial virus [12] or
influenza virus [13,14,15,16,17]. During respiratory infections, the
RANTES:CCR5 pathway has been shown to be important for
DC migration to the dLN [18], survival of alveolar macrophages
[19] and the accelerated recruitment of effector and memory T
cells to the lung after challenge [20]. Evidence that chemokines
can also regulate acute systemic infections arose from the infection
of mice lacking CCR5 with west nile virus (WNV), which resulted
in markedly higher viral titers in the central nervous system [21].
Humans with the CCR5-D32 genotype (a 32-base pair deletion in
the CCR5 open reading frame of the CCR5 gene) also have a risk
for more aggressive disease following WNV infection [22]. Thus,
the RANTES:CCR5 pathway can influence immune responses in
multiple ways during acute viral infections.
In addition to the role of the RANTES:CCR5 pathway in
coordinating spatial interactions during immune responses, CCR5
is a co-receptor for HIV [23,24]. Humans with the CCR5-D32
genotype have slower progression with HIV infection [25] and
therapeutic strategies targeting RANTES and CCR5 are being
used for treatment against HIV infection [26]. For example, the
CCR5 inhibitor maraviroc, in combination with other antiretro-
viral agents, is indicated for patients with CCR5-tropic strains of
HIV. While the benefit of maraviroc in patients with CCR5-tropic
strains of HIV is clear (maraviroc can reduce viral loads), how the
therapeutic targeting of the CCR5 pathway affects immune
responses to other pathogens is unclear.
The role of the RANTES:CCR5 pathway in respiratory
infections, WNV infection and HIV infection suggests that the
function of this pathway could be important during other viral
infections and that the effect of RANTES during HIV infection
might be complex. For example, the CCR5-D32 is beneficial
during HIV infection because of a direct impediment to viral
entry, however, this same mutation is detrimental during WNV
infection [27] as well as tick-borne encephalitis [28]. Subjects with
the CCR5-D32 mutation also have reduced DTH responses [25].
In contrast to acute infections with WNV, influenza virus and
Sendai virus, little information exists on how RANTES impacts
the T cell function or control of chronic viral infection where viral
entry is not affected by CCR5 or RANTES. Thus, we used the
mouse model of acute or chronic LCMV infection to investigate
the role of RANTES in sustaining CD8 T cell responses during
chronic infection. RANTES expression is upregulated during
acute LCMV infection [29,30] but very little is known about the
expression or role of RANTES during chronic LCMV infection.
Here we demonstrate that RANTES is upregulated to a much
higher degree during chronic LCMV infection compared to acute
LCMV infection. Unlike acute LCMV infection where RANTES
deficiency had little impact on T cell responses or viral control, the
absence of RANTES during chronic LCMV infection led to more
severe CD8 T cell exhaustion including compromised cytokine
production, higher inhibitory receptor expression and reduced
cytotoxicity. The loss of IFNc production coincided with a
decrease in Tbet expression similar to levels seen in CD4-depleted
mice during chronic LCMV infection. This increase in T cell
dysfunction in the absence of RANTES corresponded to a
substantially reduced ability to control chronic infection compared
to WT mice but was not due to an intrinsic requirement of CD8 T
cells to produce or respond to RANTES directly. These results
suggest that manipulation of the RANTES pathway may hinder
immune responses to, and thus control of, chronic infection with
some pathogens.
Materials and Methods
Mice
C57BL/6 and Ly5.1 mice were purchased from the National
Cancer Institute (NCI). CCR5
2/2 mice were purchased from
Jackson laboratories (Bar Harbor, Maine). RANTES
2/2 mice were
a gift from Michael Holtzman, Washington University St Louis and
bred in-house at AALAC-approved animal care facility at the
Wistar Institute, Philadelphia, PA. P14 mice were maintained at the
Wistar Institute and crossed to the RANTES
2/2 mice.
Viruses
For primary infections, mice were infected with either LCMV
Armstrong (2610
5 pfu) i.p. or LCMV clone 13 (2610
6 pfu) i.v. For
re-infections, mice were infected intranasally (i.n.) with recom-
binant influenza virus expressing the LCMV GP33 epitope
(x31-GP33, 1.6610
5 TCID50). Prior to i.n. infection, mice were
anaesthetized by intraperitoneal injection of ketamine hydro-
chloride and xylazine (Phoenix Scientific) in 0.2 ml of PBS.
Recombinant influenza strains were obtained from Dr. Richard J.
Webby and were propagated in specific-pathogen-free eggs and
stored at 280uC before use.
Adoptive transfer
For adoptive transfer experiments, single-cell suspensions of
CD8 T cells were equalized for the number of antigen-specific
CD8 T cells and adoptively transferred by i.v. injection into the
tail vein. CD8 T cells were purified (.90% purity) from whole
lymphocytes using magnetic beads (CD8
+ T cell isolation kit,
MACS beads; Miltenyi Biotec) and the CD8 T cells stained with
tetramer and the numbers of LCMV-specific CD8 T cells
normalized before being transferred i.v. For the P14 experiments,
LNs were isolated from P14 WT or P14 RANTES
2/2 mice. The
number of P14 cells was equalized and a total of 1,000 P14 cells
were transferred into C57BL/6 mice at a 50:50 ratio. Mice were
infected the following day with LCMV clone 13.
Bone-marrow chimeras
Ly5.1 mice from NCI were irradiated with 950 RADS. The
following day, bone-marrow cells from Ly5.1 WT mice and Ly5.2
RANTES
2/2 mice or Ly.2 CCR5
2/2 mice were depleted of T,
B and NK cells with MACs magnetic beads and adoptively
transferred i.v. at a 1:1 ratio. A total of 1–5610
6 BM cells were
transferred per mouse. Mice were fed antibiotics for 2 weeks
Author Summary
Chemokines are small proteins that attract cells and play
complex roles in coordinating immune responses. RANTES
is one such chemokine that attracts many different cell
types. The receptor for RANTES, CCR5, is also a coreceptor
for HIV and drugs blocking the RANTES:CCR5 pathway are
in clinical use to treat HIV-infected individuals. Despite the
importance of CCR5 during HIV infection, the role of
RANTES during other chronic infections remains poorly
defined. In this study, we found that the absence of
RANTES limited the ability of mice to control chronic LCMV
infection resulting in higher viral loads and more severe T
cell exhaustion. Our data suggest that the impact of
blocking the RANTES:CCR5 pathway on the ability to
control other chronic infections should be given careful
consideration when treating HIV-infected individuals.
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before use.
Isolation of lymphocytes from tissues
Mice were euthanized and the hepatic vein cut. The liver was
perfused by injecting PBS into the left heart ventricle. Livers were
incubated in 0.25 mg/ml collagenase D (Roche Diagnostics) and
1 U/ml DNase I (Roche Diagnostics) at 37uC for 30 min.
Digested livers were homogenized using a cell strainer, applied
to a 44/56% Percoll gradient, centrifuged at 850 g for 20 mins at
4uC and the lymphocyte population was harvested from the
interface. Red blood cells were lysed using ACK lysing buffer
(Quality Biological) before cells were washed and counted. Spleens
were homogenized using a cell strainer. Red blood cells were lysed
using ACK lysing buffer and the cells washed and counted.
Flow cytometry and intracellular cytokine staining
Lymphocytes isolated from different tissues were stained using
standard techniques and analyzed by flow cytometry. Virus-
specific CD4 and CD8 T cells were analyzed at the peak of the
response (LCMV day 8) and in the memory/chronic phase (.day
30). Virus-specific T cells were quantified in tissues using MHC-I
and MHC-II tetramer staining. MHC class I peptide tetramers
were made and used as described [31]. MHC-II tetramer was
obtained from the NIH Tetramer Core Facility (Emory Univer-
sity, Atlanta, GA). For examination of cytokine production, 1610
6
splenocytes were cultured in the absence or presence of the
indicated peptide (0.2 mg/ml for CD8 peptides and 2 mg/ml for
GP66-77) and brefeldin A for 5 h at 37uC. Intracellular cytokine
staining was carried out using the BD cytofix/cytoperm kit
followed by antibodies for IFNc, TNFa, IL-2 and MIP-1a.
Samples were collected using the LSR II flow cytometer (Becton
Dickinson). For CD107a staining, the antibody was added during
the stimulation as described [32].
RANTES ELISA
Activated CD8 and CD4 T cells were sorted using a FACSAria
(BD Biosciences). Cells were stimulated with PMA/ionomycin for
five hours and the supernatant used for ELISAs. The RANTES
ELISA was purchased from Peprotech (Rocky Hill, NJ) and
carried out according to the manufacturer’s instructions.
RT-PCR
D
bGP33-specific CD8 T cells and IA
bGP66-specific CD4 T
cells were sorted on a FACSAria (BD Biosciences). RNA
extraction was performed with Trizol (Invitrogen). cDNA was
generated using the High Capacity cDNA Archive Kit (Applied
Biosystems). Relative quantification real-time PCR was performed
on an ABI Prism 7000 with primers purchased from Applied
Biosystems. HPRT was used as an endogenous control. Results are
expressed relative to naı ¨ve cells.
Luminex assay
C57Bl/6 mice were infected with LCMV Armstrong or clone
13 and bled at day 8 and day 32 p.i. Serum samples were sent to
Glaxo Smithkline for examination of RANTES protein by the
luminex assay.
In vitro cytotoxicity assay
Protocol was similar to [33]. Ly5.1
+ splenocytes were labeled
with carboxyfluorescein diacetate succinimidyl ester (CFSE);
half with 100 nM CFSE and half with 1.25 mM CFSE. The
CFSE-labeled cells were then pulsed with 2 mg/ml of GP33-44 or
OVA257-264 peptide, respectively, for 90 mins at 37uC and then
rinsed three times in RPMI with 10% fetal calf serum. The peptide
pulsed targets were incubated with magnetic bead purified Ly5.2
+
CD8
+ T cells from spleens of WT or RANTES
2/2 mice with a 2:1
effector:target ratio for 18 h. Cells were washed and stained with
Ly5.1 and Live/Dead fixable red dead cell stain kit from
Invitrogen (Carlsbad, CA). The killing efficiency was determined
as previously described [33].
Statistical analysis
Data were analyzed using a two-tailed Student’s t-test and a p
value of #0.05 was considered significant.
Ethics statement
All animal experiments were performed in accordance to NIH
guidelines, the Animal Welfare Act, and US federal law. The
experiments were approved by the Wistar Institutes Institutional
Animal Care and Use (IACUC) committee, animal welfare
assurance number A3432-01. The Wistar Animal Care and Use
Program is fully accredited by the Association for Assessment and
Accreditation of Laboratory Animal Care International (AAA-
LAC).
Results
Antiviral T cell responses are similar in RANTES
2/2 and
WT mice during acute LCMV infection
Infection of mice with the Armstrong strain of LCMV results in
an acute infection that is cleared within 8–10 days. CD8 T cells
are important for the control of acute LCMV infection and
competent CD4 T cell help is required for optimal memory CD8
T cells to develop [34,35,36]. We infected both WT and
RANTES
2/2 mice with LCMV Armstrong to determine whether
RANTES played a role in regulating T cell responses to this
infection. WT and RANTES
2/2 mice were equally capable of
clearing infection with LCMV Armstrong (data not shown).
LCMV-specific CD8 T cells expanded similarly in the blood and
resulted in comparable absolute numbers of antiviral memory
CD4 and CD8 T cells (figure 1A and B). Moreover, the
expression of CD62L and CD127 on virus-specific memory T cells
on day 52 p.i. was similar in the presence or absence of RANTES
(figure 1C) suggesting that the pattern of memory T cell
differentiation was unchanged in the absence of this chemokine.
Virus-specific memory CD4 and CD8 T cells from RANTES
2/2
mice were also able to co-produce multiple cytokines equally well
(figure 1D, E and F) again showing that there was little, if any,
influence of RANTES deficiency on the pattern of differentiation
of anti-viral CD4 and CD8 T cell responses during acute LCMV
infection.
Memory CD8 T cells from RANTES
2/2 mice generate
efficient secondary responses
Given the role of the beta chemokines in regulating ‘helped’
CD8 T cell memory [7], we tested whether the memory CD8 T
cells formed during acute LCMV infection could generate an
anamnestic response, a key feature of optimal memory CD8 T
cells. WT or RANTES
2/2 mice were infected with LCMV
Armstrong to generate GP33-specific memory CD8 T cells. CD8
T cells were isolated from WT and RANTES
2/2 mice on day 52
p.i and equal numbers of D
bGP33-specific CD8 T cells were
adoptively transferred to congenically marked WT recipient mice.
These recipient mice were then infected intranasally with
influenza virus expressing the LCMV GP33 epitope (figure 2A).
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2/2 memory GP33-specific
CD8 T cells to expand upon rechallenge was assessed on day 10
p.i. Both WT and RANTES
2/2 GP33-specific CD8 T cells
expanded vigorously and to a similar degree (figure 2C).
Moreover, the RANTES
2/2 memory cells formed secondary
effector CD8 T cells that were phenotypically and functionally
similar to WT secondary effectors (figure 2D–F). Thus, memory
CD8 T cells generated in the absence of RANTES were fully
functional, responded efficiently to local infection rechallenge and
showed evidence of having received CD4 T cell help during
priming.
Memory CD8 T cells generated in the absence of RANTES
can protect from LCMV clone 13 infection
Memory CD8 T cells generated in response to LCMV
Armstrong are able to protect from infection with the more
virulent strain LCMV clone 13. To determine whether memory
CD8 T cells generated in the absence of RANTES were able to
protect from LCMV clone 13 infection, we adoptively transferred
equal numbers of either WT or RANTES
2/2 memory CD8 T
cells into naı ¨ve WT or RANTES
2/2 mice and then challenged
with LCMV clone 13. As a control, a cohort of WT mice did not
receive any cells. After 9 days, the mice were sacrificed and the
Figure 1. The absence of RANTES does not affect T cell responses to acute LCMV infection. WT and RANTES
2/2 mice were infected with
LCMV Armstrong. Mice were bled on days 8, 15, 30 and 45 p.i. and T cell responses examined. (A) The frequency of D
bGP33-specific CD8 T cells in the
blood in WT and RANTES
2/2 mice was determined. Splenocytes from WT and RANTES
2/2 mice were examined 52 days p.i. (B–F). Total numbers of
D
bGP33-specific CD8 and IA
bGP66-specific CD4 T cells in the spleen at the memory phase of the response were determined using tetramers (B).
CD62L and CD127 expression was examined on LCMV-specific memory CD4 and CD8 T cells from both WT and RANTES
2/2 mice (C). Splenocytes
from WT and RANTES
2/2 mice were stimulated with GP33 and GP66 peptides to measure cytokine responses from CD8 and CD4 T cells, respectively
(D–F). The cytokines IFNc, TNFa, IL-2 and MIP-1a were measured and representative FACs plots are shown. Graphs show total numbers per spleen.
Data are representative of 2 independent experiments with at least 4 mice per group in each experiment.
doi:10.1371/journal.ppat.1002098.g001
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any cells had high viral titers in the serum and kidneys (figure 3b).
In contrast, both WT and RANTES
2/2 mice that received either
WT or RANTES
2/2 memory CD8 T cells were protected against
chronic infection. Thus, RANTES was not required for memory
CD8 T cells to protect from LCMV clone 13 infection.
RANTES is highly expressed during chronic LCMV
infection
Infection of naı ¨ve adult mice with LCMV clone 13 results in a
chronic infection with viremia lasting 2–3 months. In contrast to
LCMV Armstrong infection, during clone 13 infection the virus-
specific CD8 T cells lose the ability to perform effector functions
efficiently. This ‘‘exhaustion’’ is hierarchical and progressive with
virus-specific CD8 T cells gradually losing the ability to produce
IL-2, proliferate robustly, kill efficiently, make TNFa and, in
severe exhaustion, produce IFNc [31]. These exhausted CD8 T
cells also express inhibitory receptors such as PD-1, LAG-3, 2B4
and CD160 [37,38]. These receptors are actively involved in
restraining CD8 T cell function during chronic infection and
blockade of these pathways can reinvigorate antiviral T cell
responses [32,38].
To begin to address the role of RANTES during chronic
i n f e c t i o nw ef i r s tm e a s u r e dR A N T E Sp r o t e i ni ns e r u m .D u r i n g
LCMV clone 13 infection, RANTES levels are increased in the
serum at day 8 and day 32 p.i. compared to naı ¨ve mice and
Figure 2. WT and RANTES
2/2 mice mount equivalent secondary responses. (A) WT and RANTES
2/2 mice were infected with LCMV
Armstrong. After ,50 days, CD8 T cells were purified from the mice and equal numbers of WT or RANTES
2/2 D
bGP33-specific CD8 T cells were
transferred into congenically marked Ly5.1 mice. The mice were then infected the following day with X31-gp33 i.n. Ten days later, the number of
donor (Ly5.2+) virus-specific CD8 T cells was enumerated by tetramer staining. Gating strategy to identify donor responses (B). WT and RANTES
2/2
memory T cells were measured in the BAL (bronchoalveolar lavage), lung and spleen of recipient mice (C). WT and RANTES
2/2 D
bGP33-specific CD8 T
cells were examined in the spleen and stained for Ly6c, CD27, KLRG1, granzyme B and CD11a (D). Production of IFNc or TNFa by the adoptively
transferred cells was measured in the spleen by peptide stimulation and ICS (E and F). Data are representative of 2 independent experiments each
with 3 mice per group.
doi:10.1371/journal.ppat.1002098.g002
Figure 3. Memory CD8 T cells do not need RANTES to protect from chronic LCMV infection. (A) WT and RANTES
2/2 mice were infected
with LCMV Armstrong. Over 30 days later, CD8 T cells were purified from the mice and 100,000 WT or RANTES
2/2 D
bGP33-specific CD8 T cells were
adoptively transferred into WT or RANTES
2/2 mice (A). The mice were then infected the following day with LCMV clone 13 i.v. Nine days later, viral
titers were measured in the spleen, kidney and sera of these mice (B). The results of two independent experiments shown in the same graph.
doi:10.1371/journal.ppat.1002098.g003
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expression was also examined at day 6 p.i., when virus was still
present in both sets of mice. Both LCMV Armstrong and
LCMV clone 13 induced RANTES expression early p.i.
(figure 4B and [39] [30]) but high amounts of circulating
RANTES were sustained only during LCMV clone 13
infection. Both LCMV-specific CD8 T cells and CD4 T cells
upregulated RANTES mRNA expression, with a high amount
of RANTES mRNA maintained in LCMV-specific CD8 T cells
past day 30 following LCMV Armstrong or clone 13 infection
(figure 4C). Given that RANTES transcription can continue in
the absence of protein production [40] and that RANTES
protein can be stored in granules in the absence of secretion
[41], we also measured secreted RANTES protein.
CD8
+CD44
hi Tc e l l sa n dC D 4
+CD44
hi T cells were sorted
from mice infected eight days previously with LCMV Arm-
strong or LCMV clone 13 and RANTES secretion measured
after 5 hours of stimulation with PMA/ionomycin. CD8 T cells
from LCMV Armstrong- or clone 13-infected mice secreted
high levels of RANTES protein following stimulation with
PMA/ionomycin (figure 4D). CD4 T cells also secreted
RANTES, though the amounts were lower compared to CD8
T cells (figure 4D). Thus, while the high amounts of
circulating RANTES found in mice with chronic LCMV
infection could come from many cell types, T cells clearly have
the potential to contribute to this circulating chemokine
production particularly in the presence of persisting antigen.
Expression of the main receptor for RANTES, CCR5, is also
upregulated on LCMV-specific CD4 and CD8 T cells during
both acute and chronic LCMV infection suggesting that not
only do T cells produce RANTES upon infection but they also
have an increased ability to bind RANTES (figure 4E).
CD8 T cell function is reduced during chronic LCMV
infection in the absence of RANTES
Given the high circulating amounts of RANTES during LCMV
clone 13 infection we next investigated whether RANTES had any
role during chronic infection. WT and RANTES
2/2 mice were
infected with LCMV clone 13 and T cell responses examined eight
days later. While the total number of D
bGP33 and D
bGP276
tetramer positive CD8 T cells as well as IA
bGP66 tetramer specific
CD4 T cells were similar in WT and RANTES
2/2 mice, the total
number of GP33- and GP276-specific CD8 T cells producing
IFNc was significantly reduced in RANTES
2/2 mice (figure 5A
and B). This difference in functionality was only observed in virus-
specific CD8 T cells but not CD4 T cells as GP66-specific CD4 T
cells from WT and RANTES
2/2 mice had similar cytokine co-
production profiles (figure 5B, C and D). Thus, CD8 T cell
responses (but not CD4 responses) are functionally compromised
at day 8 p.i. in the absence of RANTES during LCMV clone 13
infection.
To determine whether the absence of RANTES led to a
change in the development of T cell exhaustion, we examined
later timepoints during clone 13 infection. In contrast to day 8
p.i., at day 30 p.i. the number of virus-specific CD8 T cells in the
RANTES
2/2 mice determined by tetramer staining was
significantly reduced compared to WT mice (figure 6A). The
reduced LCMV-specific CD8 T cell responses in the spleen were
unlikely to be due to enhanced migration to peripheral tissues
since the LCMV-specific CD8 T cell response was not increased
in the liver (figure 6E and F). Even though both WT and
RANTES
2/2 CD8 T cells were highly dysfunctional at this time,
exhaustion was substantially more severe in the absence of
RANTES (figure 6B and 6C). Indeed, LCMV GP33- and
GP276-specific CD8 T cells were significantly less polyfunctional
(i.e. more exhausted) in RANTES
2/2 compared to WT mice
(figure 6B) suggesting that the absence of RANTES led to more
severe exhaustion of virus-specific CD8 T cells. Similar to day 8
p.i., the LCMV-specific CD4 T cell response was unaffected by
the absence of RANTES in terms of numbers of tetramer-specific
CD4 T cells and production of IFNc (figure 6G). A second
hallmark of T cell exhaustion is elevated expression of inhibitory
receptors. RANTES
2/2 virus-specific CD8 T cells had higher
expression of PD1, LAG3 and 2B4 indicating that by multiple
parameters virus-specific CD8 T cells are more exhausted in the
absence of RANTES (figure 6D).
The cytotoxic ability of CD8 T cells is critical during chro-
nic infections. While granzyme B levels were slightly higher in
LCMV-specific CD8 T cells from RANTES
2/2 mice (figure 7A),
the ability of these cells to kill was lower than WT T cells from
chronically infected mice (figure 7B). Degranulation, as mea-
sured by surface CD107a staining, was also slightly lower in
LCMV-specific CD8 T cells from RANTES
2/2 mice suggesting
that granule contents might not be released as effectively by CD8
T cells from RANTES
2/2 mice leading to an accumulation of
granzyme B intracellularly (figure 7C).
Given the reduced cytokine production and cytotoxicity in CD8
T cells from mice lacking RANTES, we examined whether these T
cell defects had an impact on viral control. At day 8 p.i., viral titers
in RANTES
2/2 mice were similar to WT mice in multiple tissues
and sera (figure 8A). However, by day 30 p.i., RANTES
2/2 mice
had higher viral load, consistent with a reduced and more
dysfunctional CD8 T cell response (figure 8A). Moreover, when
RANTES
2/2 mice were examined 3–4 months p.i., some of the
RANTES
2/2 mice still had high levels of virus in the liver and were
still viremic (figure 8A and B) while WT mice had controlled virus
from the serum. These results demonstrate that the absence of
RANTES compromises the ability to control viral replication, in
some cases leading to a long-term failure to efficiently contain
persisting infection.
Providing RANTES in trans is sufficient for normal CD8 T
cell responses to chronic infection
Given the reduction in CD8 T cell responses and greater
exhaustion in RANTES
2/2 mice we made mixed bone-marrow
chimeras to determine whether the role of RANTES was T cell
intrinsic or whether supplying RANTES in trans could prevent
more severe CD8 T cell dysfunction. Congenically marked Ly5.1
mice were lethally irradiated and reconstituted with 50% Ly5.1
BM and 50% Ly5.2 RANTES
2/2 BM (figure 9A). These mice
were infected with LCMV clone 13 and examined thirty days
later. LCMV-specific CD8 T cell responses were similar for WT
versus RANTES
2/2 CD8 T cells at this time point (figure 9B).
Moreover, in a situation where , half of the cells were able to
produce RANTES, the RANTES
2/2 CD8 T cells were as
functional as WT T cells in terms of the percentage of IFNc-
producers able to make TNFa and the MFI of IFNc (right)
(figure 9C). Finally, RANTES
2/2 T cells in the mixed chimeras
had similar expression of the inhibitory receptors 2B4, PD-1 and
LAG-3 as WT T cells (Figure 9D, E). We also used a non-bone
marrow chimera TCR transgenic adoptive transfer system to
determine whether the need for RANTES was T cell intrinsic. P14
mice bearing a T cell receptor specific for the D
bGP33 epitope
from LCMV were crossed to RANTES
2/2 mice. Equal numbers
of WT and RANTES
2/2 P14 CD8 T cells were co-transferred
into WT mice before infection with LCMV clone 13 and the CD8
T cell responses examined. Again, LCMV-specific CD8 T cells did
not need to make RANTES themselves since the expression of
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PLoS Pathogens | www.plospathogens.org 7 July 2011 | Volume 7 | Issue 7 | e1002098Figure 4. Higher concentrations of RANTES protein are present in the serum of mice infected with LCMV clone 13 compared to
LCMV Armstrong and naı ¨ve mice. (A) C57Bl/6 mice were infected with LCMV Armstrong or LCMV clone 13 and the sera examined 8 and 32 days
later for RANTES protein using luminex. (B) C57Bl/6 mice were infected with LCMV Armstrong or LCMV clone 13 and the sera examined 6 days later
for RANTES protein by ELISA. A total of three mice each were infected. Data are representative of 2 independent experiments. (C) Naı ¨ve CD8 T cells
and D
bGP33-specific CD8 T cells from day 8 and day 30 p.i. with LCMV Armstrong or clone 13 were examined for expression of RANTES mRNA by RT-
PCR. (D) Mice were infected with LCMV Armstrong or clone 13 and CD44
hi CD4 and CD8 T cells sorted on day 8 p.i. Sorted CD8 T cells were incubated
with PMA/ionomycin for 5 hours and the supernatants examined for RANTES protein. (E) C57Bl/6 mice were infected with LCMV Armstrong or LCMV
clone 13 and 8 and 30 days p.i. D
bGP33-specific CD8 T cells were examined for expression of CCR5 (grey=naı ¨ve, blue=LCMV Armstrong, red=LCMV
clone 13.
doi:10.1371/journal.ppat.1002098.g004
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WT and RANTES
2/2 P14 cells in the same chronically infected
mice (figure S1). Thus, the critical role of RANTES in sustaining
T cell responses during chronic LCMV infection was not cell
intrinsic. In other words, the defects in T cell responses to chronic
viral infections observed in the complete absence of RANTES
could be corrected by providing RANTES signals in trans.
CD8 T cells do not need intrinsic CCR5 signaling to
respond to chronic LCMV infection
While intrinsic RANTES production was not required by the
CD8 T cells, it remained possible that the CD8 T cells need to
bind RANTES themselves. To test this idea we generated mixed
bone marrow chimeras using Ly5.1 WT and Ly5.2 CCR5
2/2 BM
(figure 10A). Upon reconstitution, mice were infected with
Figure 5. The primary CD8 T cell cytokine response is diminished in the absence of RANTES at one week after clone 13 infection. WT
and RANTES
2/2 mice were infected with LCMV clone 13 and T cell responses examined eight days later. The total number of LCMV-specific CD8 and
CD4 T cells was measured by tetramer staining as well as peptide stimulation and ICS to detect cytokine production. Expression of IFNc, TNFa and
MIP1a was examined (A–D). Graphs show total numbers per spleen. Representative plots of IFNc, TNFa and MIP-1a expression (D). Data are
representative of 3 independent experiments with five mice per group.
doi:10.1371/journal.ppat.1002098.g005
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chimera system confirmed that WT LCMV-specific CD8 T cells
expressed CCR5 during chronic LCMV infection (figure 10B). A
similar response was observed for WT and CCR5
2/2 CD8 T cells
in this setting as measured by the frequency of D
bGP33 positive
CD8 T cells (figure 10C). Expression of PD-1 and production of
IFNc was also similar for WT and CCR5
2/2 LCMV-specific
CD8 T cells (figure 10D, E and F). Thus, it appears that the
major impact of RANTES during chronic LCMV infection could
be on a non-CD8 T cell and that more severe CD8 T cell
exhaustion was a symptom rather than a cause of poor control of
infection.
Absence of CD4 T cell help or RANTES results in reduced
Tbet expression during chronic infection
The transient depletion of CD4 T cells at the time of infection
with LCMV clone 13 results in life-long viremia and high viral titers
throughout the mouse [8]. This deficiency coincides with more
severe exhaustion of the CD8 T cell response demonstrated by
further diminished cytokine production [31,42]. Given the reduced
cytokine potential of RANTES
2/2 mice, we examined how this
dysfunction compared to CD4-depleted WT mice and whether
CD4 T cell depletion of RANTES
2/2 mice could further increase
the severity of exhaustion. When we compared CD8 T cell cytokine
production, we found that the reduced IFNc production in
Figure 6. CD8 T cell responses are significantly reduced in RANTES
2/2mice one month p.i. The total numbers of LCMV-specific CD8 T cells
were examined in WT and RANTES
2/2 mice 30 days p.i. with LCMV clone 13. Representative FACs plots are shown on the left (A). The ability to
produce IFNc was measured by peptide stimulation and ICS (B). The percentage of LCMV tetramer +ve cells able to make IFNc was calculated from
the total number of tetramer +ve CD8 T cells and total number of IFNc-producing T cells in response to the same peptide (C). D
bGP33-specific CD8 T
cells from WT and RANTES
2/2 mice were stained for PD-1, 2B4 and LAG3. Representative plots are shown. Numbers represent the MFI. Grey=naı ¨ve,
blue=D
bGP33-specific CD8 T cells from acute infection, red=D
bGP33-specific CD8 T cells from chronic infection (D). D
bGP33-specific CD8 T cells
were examined in the liver. Representative plots with numbers indicating the percentage of CD8 T cells that were D
bGP33-specific (E). Total numbers
of D
bGP33-specific CD8 T cells in the liver were determined by tetramer staining. (F). The total number of IA
bGP66-speciifc CD4 T cells were
determined by tetramer staining as well as peptide stimulation and ICS (G). Data are representative of three independent experiments each with at
least four mice per group.
doi:10.1371/journal.ppat.1002098.g006
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2/2 mice was similarto that ofWT micedepleted of CD4
T cells. Moreover, the depletion of CD4 T cells in RANTES
2/2
mice did not further decrease cytokine production (figure 11A).
CD4-depletion of WT and RANTES
2/2 mice ablated any
difference in cytokine potential of CD8 T cells (figure 11D)a n d
resulted in similarly high viral titers in WT and RANTES
2/2 mice
(figure 11E). This observation suggested that RANTES plays a
role in mitigating the severity of exhaustion and that either
RANTES
2/2 CD4 T cells provide little benefit to the CD8 T
cell response in RANTES
2/2 mice or the higher viral load in
RANTES
2/2 mice drives more severe CD8 T cell exhaustion
despite the CD4 T cells.
Transcription factors have recently been demonstrated to play a
key role in regulating CD8 T cell exhaustion during clone 13
infection. We have recently found that Tbet is downregulated in
exhausted CD8
+ T cells during chronic LCMV infection and this
downregulation is accentuated in the absence of CD4 help (Kao et
al. submitted) (figure 11F). This loss of Tbet results in more
severe T cell exhaustion during chronic viral infection. We
therefore next examined whether Tbet expression was impacted
by the loss of RANTES. In chronically infected RANTES
2/2
mice Tbet expression was substantially lower than in WT mice
(figure 11F). In fact, the loss of RANTES alone reduced Tbet
expression in virus-specific CD8 T cells to levels seen in CD4
depleted WT mice. To determine whether this loss of Tbet was
also seen earlier during clone 13 infection, we examined Tbet
expression at day 8 p.i. Tbet expression was already slightly
reduced by day 8 p.i. (this reduction reached significance with the
D
bGP276-specific CD8 T cells but only a trend in the D
bGP33-
specific CD8 T cells) (figure 11G). Reduced Tbet expression was
consistent with the reduction in IFNc production observed at this
early time p.i.
Figure 7. The cytotoxic ability of virus-specific CD8 T cells was decreased in the absence of RANTES. WT and RANTES
2/2 mice were
infected with LCMV clone 13 and 30 days later. LCMV-specific CD8 T cells were examined for expression of granzyme B (A). Results are shown
graphically (left) and a representative histogram is shown. Grey=Naı ¨ve CD8 T cells, Blue=D
bGP33-specific CD8 T cells from acute infection,
red=D
bGP33-specific CD8 T cells from chronic infection. Equal number of GP33-specific CD8 T cells were examined for their ability to kill CFSE-
labeled target cells (B). Surface CD107a was measured during a 5 hour stimulation (C).
doi:10.1371/journal.ppat.1002098.g007
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The role of chemokines in regulating immune responses during
chronic viral infections is poorly understood. Here we investigated
the importance of RANTES in response to a chronic infection
where CCR5 is not a viral co-receptor. RANTES was more highly
expressed during chronic LCMV infection compared to acute
infection. While the absence of RANTES did not impact T cell
responses following acute LCMV infection, a different scenario
emerged during chronic LCMV infection. During chronic
infection, CD8 T cells become exhausted and their dysfunction
was characterized by a loss of cytokine production, reduced
cytotoxicity and increased inhibitory receptor expression, all of
which can hinder the ability to control the infection [31,32,43,44].
Figure 8. Higher viral loads later during chronic LCMV infection in RANTES
2/2 versus WT mice. WT and RANTES
2/2 mice were infected
with LCMV clone 13 and viral titers were determined by plaque assay from tissues at 8, 30 and 102 days p.i. (A). Sera was also examined on days 111–
203 p.i. The graph shows the result of three independent experiments shown together (B). Ratios show the number of mice that were viremic in the
WT and RANTES
2/2 groups out of a total of 15 mice.
doi:10.1371/journal.ppat.1002098.g008
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severe with reduced virus-specific CD8 T cell numbers, cytokine
production and higher expression of inhibitory receptors. The
cytotoxic potential of virus-specific CD8 T cells responding to
clone 13 infection in RANTES
2/2 mice was also reduced
compared to WT controls. Consistent with the more severe
Figure 9. CD8 T cells do not need to produce RANTES themselves. Mixed bone-marrow chimeras were made where ,50% of the cells were
WT Ly5.1+ and ,50% RANTES
2/2 Ly5.2+ (A). Upon reconstitution, mice were infected with LCMV clone 13 and the CD8 T cell responses analyzed.
RANTES
2/2 T cells were identified by staining with Ly5.2 (B). Both the RANTES
2/2 and WT CD8 T cells were examined for their ability to produce IFNc
and TNFa (C). Representative FACs plots are shown (left) as well as a bar graph summarizing the percentage of IFNc-producers able to make TNFa
and a graph of the MFI of IFNc. Both WT and RANTES
2/2 T cells were stained for 2B4, LAG3 and PD-1 with (D) showing representative plots of
staining. Graphs plot the MFI of 2B4, LAG3 and PD-1 (E).
doi:10.1371/journal.ppat.1002098.g009
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also had higher viral loads. Thus, the absence of RANTES
resulted in the dysfunction of virus-specific CD8 T cells and poor
viral control suggesting that RANTES has an important role in
regulating and/or sustaining optimal immune responses during
chronic viral infection.
There are a number of ways in which the absence of RANTES
could result in the higher viral titers and reduced CD8 T cell
function during clone 13 infection. First, slightly higher viral loads
at the beginning of the response could lead to more severe CD8 T
cell exhaustion. One possible mechanism for RANTES affecting
viral load is via one of the main cell types infected by LCMV,
macrophages. Macrophages play a key role in the immune defense
against LCMV. Marginal zone macrophages and metallophilic
macrophages may act as filters, controlling the spread of LCMV
[45]. The increased tropism of LCMV clone 13 for macrophages
and DCs is thought to result in the ability of the virus to persist
[46]. The absence of RANTES could impact macrophage
function or survival. For example, RANTES is essential to prevent
apoptosis of macrophages infected with Sendai virus [19]. Thus, it
will be important to investigate the role of RANTES in regulating
DC and macrophage differentiation during persisting infections. A
second possibility is that RANTES regulates the homing dynamics
of the T cells, preventing T cell migration to the peripheral tissues
or microenvironments and therefore limiting the ability of these
cells to control the infection. However, during chronic LCMV
infection the LCMV-specific CD8 T cells were found in spleen,
blood and liver showing that the virus-specific T cells could still
migrate to peripheral tissues at least at the level of the whole tissue.
This observation does not rule out potential differences in
movement within tissue, however, and a more detailed analysis
of the migration dynamics of exhausted CD8 T cells in the absence
of RANTES could be important. Third, CD4 T cell help could be
reduced/absent in mice lacking RANTES. At least with LCMV
Armstrong infection, CD4 T cell help appears to be intact as CD8
T cell memory cells are fully functional upon secondary challenge.
Moreover, LCMV-specific CD4 T cell expansion and cytokine
production in RANTES
2/2 mice were similar to WT mice in
response to both LCMV Armstrong and LCMV clone 13. While
the phenotype of the CD8 T cells in RANTES
2/2 mice was
similar to CD4-depleted mice, the viral titers in mice lacking CD4
T cells was much higher suggesting that the CD4-depleted
Figure 10. CD8 T cells do not need to bind RANTES directly. Mixed bone-marrow chimeras were made where ,50% of the cells were Ly5.1+
WT and ,50% Ly5.2+ CCR5
2/2. Upon reconstitution, mice were infected with LCMV clone 13 and the CD8 T cell responses analyzed 12–20 days later
(A). The WT and CCR5
2/2 IA
bGP33-specific CD8 T cells were stained for CCR5 (B). The percentage of WT and CCR5
2/2 CD8 T cells that were GP33-
specific were determined by D
bGP33 tetramer (C). Representative staining of PD-1 on D
bGP33-specific CD8 T cells and a graph of the MFI is shown
(D). IFNc production was measured in response to GP33-44 peptide stimulation (E). Representative FACs plots are shown (left) as well as graphs
showing the percentage of the WT or CCR5
2/2 CD8 T cells producing IFNc and the MFI of IFNc (F). Data are representative of 2 independent
experiments each with at least 5 mice per group.
doi:10.1371/journal.ppat.1002098.g010
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RANTES, it is possible that CD4 T cells are an important source
of RANTES during LCMV clone 13 infection but that remains to
be determined. A fourth possibility is that RANTES directly
affects T cell activation/differentiation leading to reduced effector
functions and that loss of RANTES directly results in functional
defects in T cells leading to higher viral loads. While RANTES has
been shown to act as a costimulator of T cells [47,48], CCR5
2/2
T cells responded similarly to WT CD8 T cells in a competitive
environment suggesting that the importance of RANTES during
LCMV clone 13 infection was not due to direct costimulation of
CD8 T cells, though other receptors capable of binding RANTES
could have a role.
CD8 T cell activation/differentiation is clearly negatively
impacted by the absence of RANTES since IFNc production by
CD8 T cells was reduced even at day 8 p.i. in RANTES
2/2 mice
and this reduced IFNc production was even more dramatic at
the chronic stage of disease. Given that IFNc has been shown to
regulate the ability to clear LCMV infection [44,49,50], this
initial decrease in IFNc at the early stage of infection could result
in a reduced ability to control viral replication, leading to further
CD8 T cell exhaustion. Our data supports a role for RANTES in
allowing the efficient activation and differentiation of CD8 T
cells that are required to help control clone 13 infection.
Interestingly, RANTES was not required for memory CD8 T
cells to clear clone 13 infection. This observation, along with the
similar T cell response to acute LCMV infection supports a role
for RANTES during a sustained infection and further supports
the model that minor defects early in the response to a rapidly
disseminating infection are magnified as the infection per-
sists leading to more severe T cell dysfunction and pathogen
persistence.
Figure 11. CD4-depletion reduces Tbet and IFNc production in WT mice similar to levels seen in RANTES
2/2 mice. A cohort of WT and
RANTES
2/2 mice were depleted of CD4 T cells with GK1.5 antibody on the day prior to infection with LCMV clone 13. T cell responses were examined
35 days later. (A and B) Percentages and total numbers of LCMV-specific CD8 T cells were determined in WT and RANTES
2/2 mice depleted of CD4 T
cells for both D
bGP33-specific and D
bGP276-specific CD8 T cells using tetramer. (C)D
bGP33 and D
bGP276-specific CD8 T cells were examined for
expression of PD1, LAG3 and 2B4. Filled grey represents naı ¨ve CD8 T cells, blue=DbGP33-specific CD8 T cells from WT mice, red=DbGP33-specific
CD8 T cells from RANTES
2/2 mice. (D) Representative plots of CD107a expression and IFNc production by D
bGP33-specific CD8 T cells. Numbers
represent the percent of CD107a+ cells that are also making IFNc in response to stimulation with GP33-44 peptide. Viral titers were determined by
plaque assays in CD4-depleted WT and RANTES
2/2 mice (E). Tbet expression was determined in D
bGP33-specific CD8 T cells by flow cytometry in WT
and RANTES
2/2 mice containing CD4 T cells as well as those depleted of T cells prior to infection (F). Tbet expression was already slightly reduced by
8 days p.i. (G).
doi:10.1371/journal.ppat.1002098.g011
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cells during LCMV infection include Tbet and eomesodermin
[51,52]. Tbet expression was reduced in the absence of RANTES
during LCMV clone 13 infection. How the absence of RANTES
regulates the expression of Tbet, however, is currently unclear.
These findings do suggest that the CD8 T cells responding to clone
13 in RANTES
2/2 mice have differential expression of
transcription factors compared to those from WT mice and
perhaps these differences in transcription factor regulation impact
their effector functions. Determining whether this effect can be
directly attributed to RANTES or is a byproduct of higher viral
load requires further investigation.
Interestingly, while CD8 T cell numbers and function were
clearly reduced in the absence of RANTES, the CD4 T cells were
not as sensitive to the loss of RANTES. CD4 T cells were
unaffected in terms of numbers and the ability to produce IFNc.
Thus, the absence of RANTES had differential effects on CD4
versus CD8 T cells. These observations are somewhat surprising
given that both CD4 and CD8 T cells produce RANTES and
express the main receptor, CCR5. Further, this observation
suggests that at least some aspects of CD4 and CD8 T cell
exhaustion are regulated differently during chronic LCMV
infection. Perhaps the differential effects of RANTES on CD4
versus CD8 T cells could be due to differences in expression of the
other receptors for RANTES.
The CCR5-D32 mutation is found at a high frequency in
European populations and is thought to have arisen through
selective pressure during Yersinia pestis or variola major infection
[53]. While absence of CCR5 can clearly be protective against
HIV, CCR5 plays a role in protecting against WNV and tick-
borne encephalitis. CCR5 may also play a protective role in the
response against yellow fever virus; viscerotropic disease following
yellow fever virus (YFV) vaccination in one subject was associated
with the CCR5-D32 polymorphism as well as an additional
mutation in the RANTES promoter [54]. The dichotomy of
protection versus susceptibility of various infections and the use of
CCR5 inhibitors suggests the need for more research on subjects
with the CCR5-D32 mutation in terms of susceptibility to infection
with different pathogens.
Understanding the role of RANTES during chronic infection is
highly relevant due to the interest in CCR5 inhibitors for the
treatment of HIV. CCR5 inhibitors prevent the entry of the R5-
tropic stains of HIV virus into the cell [26]. While CCR5
inhibitors can be of tremendous benefit to those infected with the
CCR5-tropic stain of HIV, our data suggests that blocking the
RANTES pathway could negatively influence ongoing immune
responses to other persisting infections. Many patients infected
with HIV are also co-infected with other pathogens and the effect
of the RANTES:CCR5 pathway on these co-infections is not well
understood. As many as 30% of HIV-infected patients in western
Europe and the USA are coinfected with hepatitis C virus (HCV)
and complications from HCV coinfection have emerged as a
significant cause of morbidity and mortality [55,56,57]. Given the
role of RANTES in regulating responses to the flaviviruses WNV
and YFV, and that serum levels of CC-chemokines are increased
in patients infected with chronic hepatitis [58], it will be interesting
to determine whether RANTES also plays a role in regulating T
cell responses to another member of the flavivirus family HCV.
Our data suggest that therapeutic interventions targeting the
RANTES pathway could have negative effects on the ability to
control some chronic infections and indicates the need for further
research into any link between the CCR5-D32 mutation and
persistent infections. These observations also suggest that blocking
the RANTES:CCR5 receptor pathway could alter the develop-
ment and or quality of antiviral immune responses to chronic viral
infection and, therefore, CCR5 inhibitors that block only HIV
binding but not the RANTES:CCR5 pathway may be more ideal.
Supporting Information
Figure S1 RANTES deficient P14 CD8 T cells respond
similarly to WT P14 cells in a WT environment. WT and
RANTES
2/2 P14 Tg T cells were transferred into C57BL/6
mice and the mice infected with LCMV clone 13 the following
day (A). The gating strategy for identifying WT and
RANTES
2/2 P14 cells is shown (B). On days 10–14 p.i., the
WT versus RANTES
2/2 P14 cells were examined for expre-
ssion of PD-1 (C) and also cytokine production after stimulation
with GP33-44 peptide (Da n dE ). Representative FACs plots
are shown (D)a n dM F Io fI F N c as well as the percentage of
IFNc producing cells also making TNFa (E).
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